Having a part of his spleen removed and a rare chronic disease hasn’t stopped 12-year-old E’Shon Guy from living a normal ...

Family members have called for an independent investigation into CaSandra Pearson's death, saying she belonged in a hospital ...

Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...

DCGI cleared Phase III trials of Zydus’ Desidustat for sickle cell disease. If proven safe and effective, the oral drug could offer an accessible new treatment option for millions of Indians.

The first person to ever be cured of sickle cell anemia in Louisiana received revolutionary gene therapy. The treatment is now offered at this hospital.

A Nashville doctor helped pioneer an FDA approved "state-of-the-art" gene-editing therapy that could be a cure for painful ...

Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these personalized treatments faster, cheaper, and available to far more patients.

Zydus Lifesciences Limited (Zydus), an innovation-led global lifesciences company, has received permission to conduct a Phase ...

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in ...

Agios Pharmaceuticals said tebapivat fell short of expectations in a Phase 2 test in sickle cell disease. It’s the latest in ...

This deals another blow to tebapivat’s development prospects following its May 2026 termination in MDS due to efficacy ...

Zydus Lifesciences Limited, an innovation-led global lifesciences company, has received permission to conduct a phase III clinical trial of Desidustat for patients with sickle cell disease. Conducted ...